CytoVation

CytoVation

CytoVation

Lead compound CyPep-1 has world-wide patent protection and is currently in preclinical development for skin diseases and infections
Founded
2001
Raised
$2.2M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
€2,000,000
Venture capital - 2017
Team Size
2
Employees
Location
Headquarters
€2,000,000 Venture capital
FinSMEs , ArcticStartup , prnewswire

Cytovation Raises NOK20M in Funding